Graviola Max combines two species of graviola, i.e. Annona muricata and Annona montana
Graviola (Annona muricata) has become renowned for some new active ingredients, mostly found in its leaves and stems, i.e. Annonaceous acetogenins.
Graviola (Annona Muricata) has 82 different acetagenin chemicals (in 10 distinct types), besides the other species of graviola, Mountain Graviola (Annona Montana), contains the main annonocin chemical that graviola does, and it has 26 more acetogenin chemicals not found in graviola (in 6 distinct types).
Graviola Max provides 12 different types of acetogenins-108 distinct powerful chemicals in all.
READ THE LABEL OF YOUR GRAVIOLA SUPPLEMENT: all the studies on acetogenins have been conducted using leaves and stems extracts. Fruit seeds also contain these compounds, yet researchers have documented that fruit seeds might have a nurotoxic effect. Therefore, it's better off taking supplements containing only leaves and stems of graviola.
Graviola is common herbal remedy in folk medicine throughout the tropics. Different properties and uses are attributed to the different parts of the tree. Generally, the fruit, fruit juice and seeds are taken for worms and parasites, to cool fevers, to increase mother's milk after childbirth, and as an astringent for diarrhea and dysentery. The bark, leaves, and roots are considered sedative, antispasmodic, hypotensive, and nervine
Ingredients: Each capsule contains 600 mg of pure blend of graviola leaf and stem (Annona muricata), and mountain graviola leaf and stem (Annona montana). No binders, fillers, or additives are used—just 100% pure plants, rich in the naturally occurring plant chemicals that these plants are regarded for.
Suggested Use: As a dietary supplement, take 3 capsules 3- 4 times daily.
Precautions:
- Not to be used during pregnancy or breast-feeding.
- Graviola has demonstrated hypotensive, vasodilator, and cardiodepressant activities in labopratory studies. People with low blood pressure should monitor their blood pressure accordingly. Graviola may potentiate antihypertensive and cardiac depressant drugs.
- Graviola has demonstrated in vitro antimicrobial properties. Chronic, long-term use of this plant might lead to some die-off of friendly bacteria in the digestive tract. Supplementing the diet with probiotics and digestive enzymes may be helpful to counteract this possible effect.
- Graviola has demonstrated emetic properties. Large single dosages may cause nausea or vomiting. Reduce the usage accordingly or take with a meal if nausea occurs.
- Drinking plenty of water (at least 8 glasses a day) is helpful to reduce Herxheimer reactions and flush dead and dying cells from the body.
- One of three documented mechanisms of action of graviola is to decrease energy to abnormal cells (called an ATP-inhibitor). Taking supplements that increase cellular energy (like CoQ10) will counteract or disable this one mechanism of action of graviola (however, the other two mechanisms of action will be unaffected).
All the products on Naturvitae.com are "HEF". To learn more, click here.
Why should I purchase this Graviola Max? To learn more, click here.
On courtesy of Raintree Nutrition Inc.
Source: ©2007 The Health Science Institute
****The new rainforest discovery that wipes out deadly cancers in less than a year, by Alicia Potee
For more than a decade, we've been telling you about the evils of Big Pharma. But even we were shocked at the shameless greed behind the Graviola scandal, when a major drug company covered up news of the miraculous cancer cure just because it couldn't figure out a way to profit from the discovery. If it weren't for the fateful conversation between a secret insider and one brave woman, the world might never have learned about this astounding breakthrough.
Enter Leslie Taylor-a modern jungle-trekking medicine woman who spends most of her days in the company of Amazonian tribesman. She soaks up their generations-old wisdom so she can bring their secrets home to all of us. For Taylor, talking to natives and exploring the heart of South America's untouched tropical forests is just another day on the job.
So it's no surprise she was a key player in the Graviola exposé.
When a confidential source with access to Graviola's secret studies buckled under the weight of his conscience, he contacted Taylor with the truth about the tree's healing properties. Digging deeper, she discovered that there was a small body of published research out there that actually corroborated these conclusions. So she put together a harvesting operation to collect Graviola's potent leaves and stems, manned by indigenous South American tribes and located deep within the heart of the Amazon.
The silver lining that became apparent by the end of this whole ordeal is that we were able to put you in touch with a fantastic source of the miracle plant. And since we first told the world about it in 2001, Graviola has been the subject of dozens of published studies touting its unmatched power against a whole army of cancer cell lines: liver, lung, breast, skin, kidney, prostate, colon…and that's just to name a few.
But Taylor's research has continued. And recently, she told me about another form of Graviola that's just been uncovered-one that's taking the original's tumor-fighting properties to a whole new level.
A new tropical tree introduces 26 additional cancer-fighting chemicals
Mountain Graviola is a new species of the genus Anonna, the active compounds of which are called acetogenins -and Taylor discovered it herself during a visit to her South American harvesting site. Though strikingly similar in appearance to the original species of Graviola (also known as Annona muricata), she noticed that natives never ate the fruit of this new tree-while the fruit, stems, and leaves of its close relative were regularly consumed by local tribes for medicinal purposes. After questioning them as to the reason, she was told that, unlike Graviola, the fruit from the Mountain Graviola tree (or Anonna montana) was far too sour to be edible.
But a closer look at the plant's structure revealed that this substitution had been coming at a price. Although the sweeter Graviola does in fact deliver potent curative properties, the less-palatable Mountain Graviola has nearly 26 novel acetogenins that you won't find in its relative-and even more of the acetogenin annonacin, which has been the focus of most of the published studies on account of its demonstrated cancer-fighting abilities and lack of toxicity.
Because of its relative lack of use in the Amazonian culture, Taylor and her team at Raintree Nutrition are the only ones harvesting this uniquely extraordinary species of Graviola-and you won't be able to get it from any other distributors. In fact, unlike its counterpart Annona muricata, research on the specific components of Mountain Graviola has only begun to pick up in the last few years.
Novel compounds target-and destroy-ovarian and liver cancer in laboratory tests
Among the first published pieces was a pair of studies conducted in 2001 and 2002, in which Japanese scientists isolated novel acetogenins from Mountain Graviola to test their cytotoxicity against lung cancer cell lines in-vitro. The chemotherapy drug Andriamycin was used as a control. Results showed that several of these unique compounds (with a specific focus on the acetogenin montanacin) demonstrated potency in tumor growth inhibition that was comparable to the powerful, but very toxic, drug.
Additional compelling evidence has detailed Mountain Graviola's specific cytotoxicity against liver and ovarian cancer, as demonstrated by the string of studies conducted by a research team from Kaohsiung Medical University in Taiwan-two of the more recent of which were conducted in late 2004. The first tested a range of nine new acetogenins present in Mountain Graviola. Findings demonstrated that the isolated compounds acted selectively against the human ovarian cancer line 1A9 and liver cancer Hep G2 cells.
In the second study, published one month later, two of these new acetogenins (montacin and cis-montacin) were isolated and tested along with four already-known acetogenins. Results further confirmed that the new compounds selectively inhibit the proliferation of human ovarian cancer cells.
In another more recent study conducted by the same research team in 2005, two types of acetogenins were isolated from Mountain Graviola and were again subjected to a cytotoxicity assay against eight human cancer cell lines. While select compounds demonstrated moderate cytotoxic activities against six of these cancerous cell lines (including lung), all of the compounds once again showed significantly more powerful activity when pitted against cell lines of ovarian cancer, and most especially liver cancer.
New, super-strength combo wipes out deadly cancers in less than a year
While no clinical trials have been conducted for either Graviola or Mountain Graviola, I did have the benefit of reading a whole host of testimonials forwarded to me by Taylor-many from customers who had been using a new, super-strength proprietary blend of both forms of Graviola, which delivers a total of 108 documented cancer-fighting acetogenins. It's called Graviola Max-and as was originally the case seven years ago, Raintree is the first to bring it to consumers.
One woman, who was diagnosed with colon cancer for the second time in May of 2006, opted against chemotherapy after her tumor was surgically removed-choosing instead to begin a rigorous regimen of supplementation with both Graviola Max and N-Tense. According to her husband, her report seven months later was extremely encouraging, with all indicators pointing to what appears to be a full remission.
"I can truthfully say that had I not begun to use Graviola, I most likely would not be alive today," began the striking testimonial of another woman, who was diagnosed with esophageal cancer in January 2006. At the time of her diagnosis, she had been unable to consume anything but liquids.
She began supplementing with the product during her chemotherapy and radiation visits-eight months later, she was in complete remission, and able to eat solid foods once again. Today, she's cancer-free, and continues to supplement with Graviola Max.
Though it might be a while before we're actually able to see the long-term results of treatment with Graviola Max, these initial reports are more than promising. And when combined with the incredible stories of recovery we've heard from longtime Graviola users, these accounts add an entirely new dimension to the already compelling in-vitro laboratory evidence.
Because Graviola Max is so strong, Taylor doesn't recommend that it be used as a preventive. She also cautioned that reports of nausea have climbed 20 percent with this product-a common side effect of the formula's main cancer-fighting chemical, annonacin.
Admittedly, it's a small price to pay for survival-but based on this demand, Taylor has also developed a new tincture called Stomach-Ez (made from the extracts of a variety of South American tropical plants) to help eliminate any queasiness or vomiting that might result from your supplementation with Graviola Max."
References
The new rainforest discovery that wipes out deadly cancers in less than a year
1 Wang LQ, et al. "Annonaceous acetogenins from the leaves of Annona montana." Bioorg. Med. Chem. 2002; 10(3):561-5.
2 Wang LQ, et al. "Cytotoxic monotetrahydrofuran ring acetogenins from leaves of Annona montana." Planta Med. 2001 Dec; 67(9): 807-11.
3 Liaw CC, Chang FR, Wu CC, et al. "Nine new cytotoxic monotetrahydrofuranic Annonaceous acetogenins from Annona montana." Planta Med. 2004 Oct; 70(10): 948-59.
4 Liaw CC, Chang FR, Wu CC, et al. "Montacin and cis-montacin, two new cytotoxic monotetrahydrofuranic annonaceous acetogenins from Anonna montana." J Nat Prod. 2004 Nov;67(11):1804-8.
5 Chih-Chuang L, Fang-Rong C, Shu-Li C, et al. "Novel cytotoxic monotetrahydrofuranic Annonaceous acetogenins from Annona montana." Bioorg. Med. Chem. 2005 Aug 1; 13 (15):4767-76.***
References Graviola (Annona muricata)
Takahashi, J. A., et al. “Antibacterial activity of eight Brazilian Annonaceae plants.” Nat. Prod. Res. 2006; 20(1): 21-6.
Kojima, N. “Systematic synthesis of antitumor Annonaceous acetogenins” Yakugaku Zasshi. 2004; 124(10): 673-81
Yuan, S. S., et al. “Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1 phase and causes cytotoxicity in a Bax- and caspase-3-related pathway.” Life Sci. 2003 May: 72(25): 2853-61.
Liaw, C. C., et al. “New cytotoxic monotetrahydrofuran Annonaceous acetogenins from Annona muricata.” J. Nat. Prod. 2002; 65(4): 470-75.
Gonzalez-Coloma, A., et al. “Selective action of acetogenin mitochondrial complex I inhibitors.” Z. Naturforsch. 2002; 57(11-12): 1028-34.
Chang, F. R., et al. “Novel cytotoxic Annonaceous acetogenins from Annona muricata.” J. Nat. Prod. 2001; 64(7): 925-31.
Padma, P., et al. “Effect of Annona muricata and Polyalthia cerasoides on brain neurotransmitters and enzyme monoamine oxidase following cold immobilization stress.” J. Natural Remedies 2001; 1(2): 144-46.
Jaramillo, M. C., et al. “Cytotoxicity and antileishmanial activity of Annona muricata pericarp.” Fitoterapia. 2000; 71 (2): 183-6.
Betancur-Galvis, L., et al. “Antitumor and antiviral activity of Colombian medicinal plant extracts.” Mem. Inst. Oswaldo Cruz. 1999; 94(4): 531-35.
Kim, G. S., et al. “Muricoreacin and murihexocin C, mono-tetrahydrofuran acetogenins, from the leaves of Annona muricata.” Phytochemistry. 1998; 49(2): 565-71.
Kim, G. S., et al. “Two new mono-tetrahydrofuran ring acetogenins, annomuricin E and muricapentocin, from the leaves of Annona muricata.” J. Nat. Prod. 1998; 61(4): 432-36.
Nicolas, H., et al. “Structure-activity relationships of diverse Annonaceous acetogenins against multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells.” J. Med. Chem. 1997; 40(13): 2102-6.
Zeng, L., et al. “Five new monotetrahydrofuran ring acetogenins from the leaves of Annona muricata.” J. Nat. Prod. 1996; 59(11): 1035-42.
Wu, F. E., et al. “Two new cytotoxic monotetrahydrofuran Annonaceous acetogenins, annomuricins A and B, from the leaves of Annona muricata.” J. Nat. Prod. 1995; 58(6): 830-36.
Wu, F. E., et al. “Additional bioactive acetogenins, annomutacin and (2,4-trans and cis)-10R-annonacin-A-ones, from the leaves of Annona muricata.” J. Nat. Prod. 1995; 58(9): 1430-37.
Wu, F. E., et al. “New bioactive monotetrahydrofuran Annonaceous acetogenins, annomuricin C and muricatocin C, from the leaves of Annona muricata.” J. Nat. Prod. 1995; 58(6): 909-5.
Wu, F. E., et al. “Muricatocins A and B, two new bioactive monotetrahydrofuran Annonaceous acetogenins from the leaves of Annona muricata.” J. Nat. Prod. 1995; 58(6): 902-8.
Sundarrao, K., et al. “Preliminary screening of antibacterial and antitumor activities of Papua New Guinean native medicinal plants.” Int. J. Pharmacog. 1993; 31(1): 3-6.
Heinrich, M., et al. “Parasitological and microbiological evaluation of Mixe Indian medicinal plants (Mexico).” J. Ethnopharmacol. 1992; 36(1): 81–5.
Mountain Graviola (Annona montana)
Liaw, C. C., et al. “Novel cytotoxic monotetrahydrofuranic Annonaceous acetogenins from Annona montana.” Bioorg. Med. Chem. 2005 Aug; 13(15): 4767-76.
Tormo, J. R., et al. “In vitro antitumor structure-activity relationships of threo/trans/threo/trans/erythro bis-tetrahydrofuranic acetogenins: correlations with their inhibition of mitochondrial complex I.” Oncol. Res. 2005; 15(3): 129-38.
Liaw, C. C., et al. “Montacin and cis-montacin, two new cytotoxic monotetrahydrofuran Annonaceous acetogenins from Annona montana.” J. Nat. Prod. 2004; 67(11): 1804-8.
Liaw, C. C., et al. “Nine new cytotoxic monotetrahydrofuranic Annonaceous acetogenins from Annona montana.” Planta Med. 2004; 70(10): 948-59.
Kojima, N. “Systematic synthesis of antitumor annonaceous acetogenins.” Yakugaku Zasshi. 2004; 124(10): 673-81
Wang, L. Q., et al. “Annonaceous acetogenins from the leaves of Annona montana.” Bioorg. Med. Chem. 2002; 10(3): 561-5.
Wang, L. Q., et al. “Cytotoxic mono-tetrahydrofuran ring acetogenins from leaves of Annona montana.” Planta Med. 2001 Dec; 67(9): 847-52.
Mootoo, B. S., et al. “Three novel monotetrahydrofuran annonaceous acetogenins from Annona montana.”J. Nat. Prod. 2000; 63(6): 807-11.
Yang, S., et al. “Chemical constituents of Annonaceae plants and their antitumor activities.” Zhongguo Yi. Xue. Ke. Xue. Yuan. Xue. Bao. 2000 Aug; 22(4): 376-82.
Wang, L. Q., et al. “Four mono-tetrahydrofuran ring acetogenins, montanacins B-E, from Annona montana.” Chem. Pharm. Bull. 2000; 48(8): 1109-13.
Wu, Y. C., et al. “Bioactive constitutents from the stems of Annona montana.” Planta Med. 1995 Apr; 61(2): 146-9.
Jossang, A., et al. “Annomonysvin: a new cytotoxic gamma-lactone-monotetrahydrofuranyl acetogenin from Annona montana.” J. Nat. Prod. 1991 Jul-Aug; 54(4): 967-71.
Following up, an article on Graviola proprieties by Health Science Institute and with kindly licence of Raintree Nutrition:
Billion-dollar drug company nearly squashes astounding research on natural cancer killer
Colon and breast cancer conquered with miracle tree from the Amazon found to be 10,000 times stronger than chemotherapy
Since our inception in 1996, Health Sciences Institute has scoured the world to find cutting-edge treatments few people have access to or have even heard about. And sometimes, what we uncover startles even the medical mavericks on our board.
Two months ago, we learned about an astounding cancer-fighting tree from the Amazon that has literally sent shock waves through the HSI network.
Today, the future of cancer treatment and the chances of survival look more promising than ever. There's a healing tree that grows deep within the Amazon rain forest in South America that could literally change how you, your doctor, and possibly the rest of the world think about curing cancer.
With extracts from this powerful tree, it may now be possible to…
- conquer cancer safely and effectively with an all-natural therapy that doesn't cause extreme nausea, weight loss, and hair loss
- protect your immune system and evade deadly infections
- feel strong and healthy throughout the course of treatment
- boost your energy and improve your outlook on life
Through a series of confidential communications involving a researcher from one of America's largest pharmaceutical companies, this ancient tree's anticancerous properties have recently come to light. Although not yet tested in human trials, the tree has been studied in more than 20 laboratory tests since the 1970s, where it's been shown that:
- effectively target and kill malignant cells in 12 different types of cancer, including colon, breast, prostate, lung, and pancreatic cancer
- be 10,000 times stronger in killing colon cancer cells than Adriamycin, a commonly used chemotherapeutic drug
- selectively hunt down and kill cancer cells without harming healthy cells, unlike chemotherapy
So why isn't every health publication extolling the benefits of this treatment? Why hasn't it been made widely available throughout the natural-medicine community? And, if it's only half as promising as it appears to be, why isn't every oncologist at every major hospital insisting on using it on all his patients? Especially when you consider that since the early 1990s, extensive independent research-including research by one of today's leading drug companies and by the National Cancer Institute-confirms that the tree's chemical extracts attack and destroy cancer cells with lethal precision.
The answer to these difficult questions can only be explained by recounting a disturbing story we recently uncovered. More than anything else we've reported on this year, the story of this Amazon cancer treatment reinforces the need for groups like HSI and illustrates how easily our options for medical treatment are controlled by money and power.
News of this amazing tree was nearly lost forever
A confidential source, whose account we've been able to independently confirm, revealed that a billion-dollar drug company in the United States tried for nearly seven years to synthesize two of the tree's most powerful anticancerous chemicals. In the early 1990s, behind lock and key, this well-known drug giant began searching for a cure for cancer-while preciously guarding their opportunity to patent it and, therefore, profit from it.
Research focused on a legendary healing tree called Graviola. Parts of the tree-including the bark, leaves, roots, fruit, and fruit seeds-had been used for centuries by medicine men and native Indians in South America to treat heart disease, asthma, liver problems, and arthritis. Going on little documented scientific evidence, the company poured money and resources into testing Graviola's anticancerous properties-and they were shocked by the results. Graviola was a cancer-killing dynamo. But that's where the story of Graviola nearly ended.
The pharmaceutical company had a big problem. They'd spent years trying to isolate and create man-made duplicates of two of the tree's most powerful chemicals. But they'd hit a brick wall. They couldn't replicate the original. And they couldn't sell the tree extract itself profitably-because federal law mandates that natural substances can't be patented. That meant the company couldn't protect its profits on the project it had poured millions of dollars and nearly seven years of research into.
As the dream of big profits evaporated, testing on Graviola came to a screeching halt
After seven frustrating years and without the promise of lucrative sales, the company shelved the project and refused to publish its findings in an independent journal. But one responsible researcher struggled with the decision. While understanding the company's goal of profits, he couldn't accept the decision to hide this unique cancer killer from the world. Following his conscience and risking his career, he contacted Raintree Nutrition, a company dedicated to harvesting plants from the Amazon.
As a result, Raintree went into high gear and began to research related studies published on Graviola. They discovered that several other teams in the United States (in addition to that of the drug company) had been testing Graviola in vitro (in test tubes). The results supported the drug company's secret findings; Graviola had been shown to kill cancer cells.
Encouraged by these early laboratory tests, Raintree hired indigenous Indian tribes in Brazil to grow and harvest the tree. They spent a year on research and development and then began offering Graviola in the United States. They also developed a new supplement called N-Tense, which contains 50 percent Graviola as well as smaller amounts of seven other cancer-killing botanical extracts.
Health Sciences Institute came across Graviola and Raintree Nutrition a few months ago while researching Chanca Piedra, a natural kidney-stone therapy from the Amazon, that was featured in our September 2000 issue. In the course of our working together, Raintree pointed us toward Graviola. And needless to say, our panel of experts were intrigued by the possibility of this powerful natural cure for cancer.
Graviola hunts down and destroys prostate, lung, breast, colon, and pancreatic cancers… leaving healthy cells alone
Since November, we've been looking closely into the research to date on Graviola. It appears one of the first scientific references to it in the United States was by the National Cancer Institute (NCI). In 1976, the NCI included Graviola in a plant-screening program that showed its leaves and stems were effective in attacking and destroying malignant cells. But the results were part of an internal NCI report and were, for some reason, never released to the public.
Since 1976, there have been several promising cancer studies on Graviola. However, the tree's extracts have yet to be tested on cancer patients. No double-blind clinical trials exist, and clinical trials are typically the benchmark mainstream doctors and journals use to judge a treatment's value. Nevertheless, Graviola has been shown to kill cancer cells in vitro in at least 20 laboratory tests that our research has uncovered.
The most recent study, conducted at Catholic University of South Korea earlier this year, revealed that two chemicals extracted from Graviola seeds showed "selective cytotoxicity comparable with Adriamycin" for breast and colon cancer cells. The chemicals targeted and killed malignant breast and colon cells in a test tube-comparable to the commonly used chemotherapy drug Adriamycin.2
Another study, published in the Journal of Natural Products, showed that Graviola is not only comparable to Adriamycin-but dramatically outperforms it in laboratory tests. Results showed that one chemical found in Graviola selectively killed colon cancer cells at "10,000 times the potency of Adriamycin."
Other promising and ongoing research at Purdue University is supported by a grant from the National Cancer Institute. Purdue researchers recently found that leaves from the Graviola tree killed cancer cells "among six human-cell lines" and were especially effective against prostate and pancreatic cancer cells.
In a separate study, Purdue researchers showed that extracts from the Graviola leaves are extremely effective in isolating and killing lung cancer cells.
Perhaps the most significant result of the study cited above from the Catholic University of South Korea, and of each of the others we've found, is that Graviola was shown to selectively target the enemy-leaving all healthy, normal cells untouched. By comparison, chemotherapy indiscriminately seeks and destroys all actively reproducing cells-even normal hair and stomach cells. This is what causes such often-devastating side effects as hair loss and severe nausea. In this respect, Graviola looks to be a promising alternative or supplement to mainstream treatments.
Patient reports show Graviola and N-Tense help eliminate tumors
From a clinical standpoint, Graviola still has a long way to go. Its properties have only been studied in a test tube. That's why it has yet to become widely known and accepted. The unfortunate truth is that without the promise of huge revenues from a synthesized, patented drug, it's unlikely that any pharmaceutical company will invest the hundreds of thousands (even millions) of dollars it would take to conduct the double-blind, placebo-controlled studies on humans. This is the underlying challenge to substantiating most nutritional therapies. Fortunately, Graviola is a natural substance, so we don't have to wait around for the drug companies. And, thanks to one researcher with a conscience, Raintree Nutrition bravely took the initiative in making this promising cure available.
Only a relative handful of doctors and patients in the United States have been using Graviola and the Graviola-rich botanical supplement N-Tense to fight cancer. Still, according to Raintree Nutrition, the combined therapy has produced some incredible results.
One such case history involved an executive at a high-tech company in Texas. Daryl S. came across Raintree when exploring alternative treatments to cure his prostate cancer. A sonogram and biopsy confirmed that Daryl had more than 20 tumors in his prostate. One doctor recommended surgery. But Daryl thought a cure using this common conventional treatment would come at too great a cost. He didn't want to suffer from impotence and incontinence for the rest of his life.
Instead, he agreed to a far less invasive round of hormonal therapy (to shrink the size of his prostate) and began a rigorous supplement regimen that centered around the Graviola-rich supplement N-Tense.
Within two months, Daryl's PSA level had dropped from 4.1 to 0.00. A sonogram and several other gamma-ray tests later confirmed that all the malignant tumors inside his prostate had disappeared.
Seven years of silence broken
We are continuing to work with Raintree and others conducting ongoing research on Graviola. As more scientific and anecdotal evidence comes to light, you'll be among the first to hear about it. However, after seven years of silence and hidden research, we felt it irresponsible not to bring this to you now.
Grown and harvested by indigenous people in Brazil, Graviola is available in limited supply in the United States and distributed only through Raintree Nutrition. But now, you can be among a select few in the entire country to benefit from Graviola. We encourage you, as always, to consult with your doctor before beginning any new therapy, especially when treating cancer.
Despite the mounting collection of laboratory tests and anecdotal reports about this cancer-fighting dynamo, Graviola may always remain an underground therapy!
Graviola has yet to be clinically tested on animals or humans. And because Graviola is a natural product, it can't be patented. Without the promise of exclusive sales and high profitability, it will likely never again draw the attention of a major drug company or research lab. So we may never see a double-blind clinical study on the tree that's reported to help defeat cancer.
But there's no doubt about it-the early laboratory tests and anecdotal reports about Graviola are very exciting. And if you've been diagnosed with cancer, you and your doctor should look at all the available treatment options. Graviola may just provide the help you've been looking for that could make all the difference in beating cancer.
Raintree Nutrition can supply you with more information on Graviola and N-Tense. See page 8 for ordering and contact information.
Graviola fights more than cancer…
While the research on Graviola has focused on its cancer-fighting effect, the plant has been used for centuries by medicine men in South America to treat an astonishing number of ailments, including:
- hypertension
- influenza
- rashes
- neuralgia
- arthritis
- rheumatism
- diarrhea
- nausea
- dyspepsia
- ulcers
- ringworm
- scurvy
- malaria
- dysentery
- palpitations
- nervousness
- insomnia
- fever
- boils
- muscle spasm
WARNINGS: The statements given in these pages have an informative aim and are drawned on international publications. Information, statements and products on this website have not been evaluated by the FDA and are not intended to diagnose, mitigate, treat, cure, or prevent any disease or health condition. The natural properties of the botanicals are only referred to their common uses among folk and herbal traditions. Our products are not intended to diagnose, cure, or prevent any disease as well. It's not meant to give any suggestion of diagnosis or disesase treatment. Please see a doctor when needed.